0001127602-24-013937.txt : 20240502 0001127602-24-013937.hdr.sgml : 20240502 20240502161108 ACCESSION NUMBER: 0001127602-24-013937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240430 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams David Michael CENTRAL INDEX KEY: 0001820958 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 24908338 MAIL ADDRESS: STREET 1: MERCK & CO., INC. STREET 2: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-30 0000310158 Merck & Co., Inc. MRK 0001820958 Williams David Michael MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 EVP,Chief Info&Digital Officer 0 Common Stock 19875.918 D Stock Option (Right to Buy) 129.22 2024-04-30 4 A 0 16406 0 A 2025-04-30 2034-04-29 Common Stock 16406 16406 D Holdings include shares acquired in dividend reinvestment transactions. The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. /s/ Kelly E. W. Grez as Attorney-in-Fact for David Michael Williams 2024-05-02